Table of Contents
Table 5-78: Switzerland
Table 5-80: Tipton
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2001 | 1997 - 2001 | 2001 | 1997 - 2001 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 281 | 585.8 | 1,374 | 579.3 | 123 | 275.8 | 601 | 273.7 |
| Esophagus | * | # | 16 | 6.4** | * | # | 21 | 8.7 |
| Stomach | 7 | 13.1** | 20 | 8.0 | * | # | 8 | 3.3** |
| Colon excluding Rectum | 17 | 38.7** | 107 | 48.4 | 8 | 18.8** | 36 | 17.4 |
| Rectum and Rectosigmoid Junction | 11 | 23.5** | 49 | 21.3 | 5 | 12.0** | 15 | 6.6** |
| Liver | * | # | 9 | 3.7** | * | # | 10 | 4.3** |
| Pancreas | * | # | 22 | 9.2 | 6 | 11.7** | 29 | 12.7 |
| Lung and Bronchus | 55 | 115.3 | 258 | 112.4 | 42 | 90.0 | 208 | 92.0 |
| Melanoma of the Skin | 11 | 20.5** | 50 | 20.1 | * | # | 8 | 3.8** |
| Prostate | 73 | 153.5 | 333 | 143.7 | 15 | 40.3** | 61 | 32.7 |
| Urinary Bladder | 20 | 43.3 | 94 | 41.3 | * | # | 13 | 6.5** |
| Kidney and Renal Pelvis | 12 | 24.4** | 54 | 21.2 | * | # | 26 | 11.6 |
| Brain and Other Nervous System | * | # | 27 | 9.7 | * | # | 18 | 7.1** |
| Non-Hodgkin Lymphoma | 12 | 23.8** | 67 | 27.4 | 6 | 12.4** | 31 | 14.5 |
| Myeloma | 8 | 18.1** | 20 | 8.9 | 5 | 11.0** | 14 | 6.8** |
| Leukemia | 10 | 23.2** | 50 | 20.5 | 7 | 16.9** | 25 | 10.7 |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2001 | 1997 - 2001 | 2001 | 1997 - 2001 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 278 | 444.2 | 1,356 | 441.5 | 90 | 143.8 | 558 | 178.4 |
| Colon excluding Rectum | 26 | 40.7 | 115 | 37.0 | 8 | 12.1** | 40 | 12.2 |
| Rectum and Rectosigmoid Junction | 8 | 12.6** | 34 | 10.7 | * | # | 11 | 3.4** |
| Liver | * | # | 2 | # | * | # | 2 | # |
| Pancreas | 6 | 9.8** | 42 | 13.2 | 9 | 13.8** | 40 | 12.4 |
| Lung and Bronchus | 30 | 49.4 | 158 | 52.3 | 23 | 37.7 | 128 | 42.1 |
| Melanoma of the Skin | 12 | 19.7** | 35 | 11.6 | * | # | 10 | 3.1** |
| Breast | 95 | 154.5 | 424 | 141.6 | 11 | 17.4** | 81 | 26.0 |
| Cervix Uteri | 5 | 6.9** | 25 | 7.9 | * | # | 5 | 1.7** |
| Corpus Uteri | 22 | 35.9 | 82 | 27.7 | * | # | 9 | 3.1** |
| Ovary | * | # | 51 | 16.3 | 6 | 9.7** | 33 | 10.8 |
| Urinary Bladder | 5 | 7.7** | 34 | 10.8 | * | # | 10 | 2.9** |
| Kidney and Renal Pelvis | 9 | 14.2** | 41 | 13.4 | * | # | 13 | 4.3** |
| Brain and Other Nervous System | * | # | 16 | 5.2** | * | # | 16 | 5.4** |
| Non-Hodgkin Lymphoma | 12 | 19.3** | 44 | 14.2 | * | # | 25 | 7.8 |
| Myeloma | 6 | 9.1** | 25 | 8.1 | * | # | 9 | 2.7** |
| Leukemia | 7 | 11.4** | 31 | 9.6 | * | # | 12 | 3.9** |
Rates are per 100,000; Age-adjusted, 2000 U.S. Standard Million.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, February 2005
Table of Contents
Table 5-78: Switzerland
Table 5-80: Tipton
